ELTX
Price
$10.32
Change
-$0.06 (-0.58%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
168.94M
OBIO
Price
$2.70
Change
-$0.14 (-4.93%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
146.22M
Interact to see
Advertisement

ELTX vs OBIO

Header iconELTX vs OBIO Comparison
Open Charts ELTX vs OBIOBanner chart's image
Elicio Therapeutics
Price$10.32
Change-$0.06 (-0.58%)
Volume$600
Capitalization168.94M
Orchestra BioMed Holdings
Price$2.70
Change-$0.14 (-4.93%)
Volume$16.09K
Capitalization146.22M
ELTX vs OBIO Comparison Chart in %
Loading...
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELTX vs. OBIO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELTX is a StrongBuy and OBIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ELTX: $10.38 vs. OBIO: $2.84)
Brand notoriety: ELTX and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELTX: 112% vs. OBIO: 135%
Market capitalization -- ELTX: $168.94M vs. OBIO: $146.22M
ELTX [@Biotechnology] is valued at $168.94M. OBIO’s [@Biotechnology] market capitalization is $146.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELTX’s FA Score shows that 1 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • ELTX’s FA Score: 1 green, 4 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ELTX is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELTX’s TA Score shows that 3 TA indicator(s) are bullish while OBIO’s TA Score has 4 bullish TA indicator(s).

  • ELTX’s TA Score: 3 bullish, 5 bearish.
  • OBIO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ELTX is a better buy in the short-term than OBIO.

Price Growth

ELTX (@Biotechnology) experienced а -7.73% price change this week, while OBIO (@Biotechnology) price change was +16.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELTX($169M) has a higher market cap than OBIO($146M). ELTX YTD gains are higher at: 103.529 vs. OBIO (-29.000). ELTX has higher annual earnings (EBITDA): -52.72M vs. OBIO (-70.94M). OBIO has more cash in the bank: 33.9M vs. ELTX (22.1M). ELTX has less debt than OBIO: ELTX (14.9M) vs OBIO (16.4M). OBIO has higher revenues than ELTX: OBIO (2.94M) vs ELTX (0).
ELTXOBIOELTX / OBIO
Capitalization169M146M116%
EBITDA-52.72M-70.94M74%
Gain YTD103.529-29.000-357%
P/E Ratio5.96N/A-
Revenue02.94M-
Total Cash22.1M33.9M65%
Total Debt14.9M16.4M91%
TECHNICAL ANALYSIS
Technical Analysis
ELTXOBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 3 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 9 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BVLDF0.01N/A
N/A
Bold Ventures, Inc.
PGINF4.16N/A
N/A
Prestige International Inc.
UNLRY2.10N/A
N/A
PT Unilever Indonesia Tbk
VACBF0.21N/A
N/A
NYKODE THERAPEUTICS AS
NRILY39.58-0.33
-0.83%
Nomura Research Institute Ltd.

ELTX and

Correlation & Price change

A.I.dvisor tells us that ELTX and PCVX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELTX and PCVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELTX
1D Price
Change %
ELTX100%
-2.08%
PCVX - ELTX
31%
Poorly correlated
+0.99%
CORT - ELTX
29%
Poorly correlated
+0.23%
TNGX - ELTX
28%
Poorly correlated
+3.29%
OBIO - ELTX
28%
Poorly correlated
-5.33%
LVTX - ELTX
27%
Poorly correlated
+1.97%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with XBIT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then XBIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-5.33%
XBIT - OBIO
41%
Loosely correlated
-0.57%
BEAM - OBIO
39%
Loosely correlated
+1.32%
ADVM - OBIO
39%
Loosely correlated
-3.80%
OCUL - OBIO
39%
Loosely correlated
N/A
RXRX - OBIO
38%
Loosely correlated
+1.24%
More